Literature DB >> 21442659

Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.

Anna Prats París1, Heidi Guerra Saleta, Maria de la Cruz Crespo Maraver, Emmanuel Silvestre, Maite Garolera Freixa, Cristina Petit Torrellas, Silvia Alonso Pont, Marc Fabra Nadal, Sheila Alcaine Garcia, Maria Victoria Perea Bartolomé, Valentina Ladera Fernández, Angels Rusiñol Bayés.   

Abstract

The aim of this study was to analyze the efficacy of a cognitive training program on cognitive performance and quality of life in nondemented Parkinson's disease patients. Participants who met UK Brain Bank diagnosis criteria for Parkinson's disease, with I-III Hoehn & Yahr, aged 50-80, and nondemented (Mini-Mental State Examination ≥ 23) were recruited. Patient's cognitive performance and functional and quality-of-life measures were assessed with standardized neuropsychological tests and scales at baseline and after 4 weeks. Subjects were randomly and blindly allocated by age and premorbid intelligence (Vocabulary, Wechsler Adult Intelligence Scale-III) into 2 groups: an experimental group and a control group. The experimental group received 4 weeks of 3 weekly 45-minute sessions using multimedia software and paper-and-pencil cognitive exercises, and the control group received speech therapy. A total of 28 patients were analyzed. Compared with the control group participants (n = 12), the experimental group participants (n = 16) demonstrated improved performance in tests of attention, information processing speed, memory, visuospatial and visuoconstructive abilities, semantic verbal fluency, and executive functions. There were no observable benefits in self-reported quality of life or cognitive difficulties in activities of daily living. We concluded that intensive cognitive training may be a useful tool in the management of cognitive functions in Parkinson's disease. © 2011 Movement Disorder Society.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21442659     DOI: 10.1002/mds.23688

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  55 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

Review 2.  Prospective memory functioning: a new area of investigation in the clinical neuropsychology and rehabilitation of Parkinson's disease and mild cognitive impairment. Review of evidence.

Authors:  Alberto Costa; Giovanni Augusto Carlesimo; Carlo Caltagirone
Journal:  Neurol Sci       Date:  2012-01-20       Impact factor: 3.307

3.  Effects of Non-Pharmacological Treatments on Quality of Life in Parkinson's Disease: A Review.

Authors:  Sangwoo Ahn; Yan Chen; Tim Bredow; Corjena Cheung; Fang Yu
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2017-04-20

4.  Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study.

Authors:  Antonio Cerasa; Maria Cecilia Gioia; Maria Salsone; Giulia Donzuso; Carmelina Chiriaco; Sabrina Realmuto; Alessandra Nicoletti; Gabriele Bellavia; Aurelia Banco; Marco D'amelio; Mario Zappia; Aldo Quattrone
Journal:  Neurol Sci       Date:  2014-02-20       Impact factor: 3.307

5.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

6.  A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.

Authors:  Natalia Adamski; Matthias Adler; Klaus Opwis; Iris-Katharina Penner
Journal:  Ther Adv Neurol Disord       Date:  2016-02-16       Impact factor: 6.570

7.  Veering in hemi-Parkinson's disease: Primacy of visual over motor contributions.

Authors:  Xiaolin Ren; Robert Salazar; Sandy Neargarder; Serge Roy; Terry D Ellis; Elliot Saltzman; Alice Cronin-Golomb
Journal:  Vision Res       Date:  2015-09-12       Impact factor: 1.886

8.  Sustained attention training reduces spatial bias in Parkinson's disease: a pilot case series.

Authors:  Joseph DeGutis; Mallory Grosso; Thomas VanVleet; Michael Esterman; Laura Pistorino; Alice Cronin-Golomb
Journal:  Neurocase       Date:  2015-09-11       Impact factor: 0.881

9.  Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-10

Review 10.  Parkinson disease-associated cognitive impairment.

Authors:  Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub
Journal:  Nat Rev Dis Primers       Date:  2021-07-01       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.